기초교실 - 교수진 소개

김정열 교수

김정열 교수

김정열 / Chungyeul Kim

  • 소속병리학교실
  • 직위교수
  • 세부전공유방병리, 분자병리
  • 연구실위치
  • 구내전화번호
  • 팩스
  • 이메일idea1@korea.ac.kr
학력사항
1988.03.01.~1994.02.25 고려대학교 의학과 학사
1998.03.01.~2000.02.25 고려대학교 의학과 석사
2012.07.01.~2016.02.25 고려대학교 의학과 박사
교육 및 경력사항
1994.04.01.~1997.04.25 Public Health Care Physician: Public Health Center of Iksan city, Chonbuk, Korea
1997.05.01.~1998.02.25 Internship: Korea University Hospital, Seoul, Korea
1998.03.01.~2002.02.25 Residency: Department of Pathology Korea University Hospital, Seoul, Korea
2002.05.01.~2004.12.31 Research Fellowship Department of Pathology NSABP Foundation Inc. Pittsburgh, USA
2005.01.01.~2012.06.25 Molecular pathology Laboratory manager Department of Pathology NSABP Foundation Inc. Pittsburgh. USA
2012.07.01.~2015.08.01 clinical associate professor, pathology department, Korea university Guro hospital
2015.09.01.~2020.08.31 clinical professor, pathology department, Korea university Guro hospital
학술활동
2002 - 현재 대한병리학회 정회원
2002 - 현재 대한세포병리학회 정회원
2012 - 현재 한국유방암학회 정회원
2012 - 현재 유방병리연구회 학술
2017 - 현재 대한병리학회 보험간사
2017 - 현재 한국유방암학회 임상시험위원회 연구심의소위원회 위원
대표논문
1. Yoo Sang BAEK, Jiehyun JEON, Aeree KIM ,Hae Jun SONG, Chungyeul KIM. Human papillomavirus is more frequently detected in the pelvic than non-pelvic area in patients with squamous cell carcinoma in situ (Bowen’s disease). Eur J Dermatol 2020; xx(x): 1-8
2. Kim J, Kim A, Kim C. Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit. Oncol Lett. 2019 Feb;17(2):1812-1818. doi: 10.3892/ol.2018.9784.
3. Kim C, Go EJ, Kim A. Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment. Biomarkers. 2018 Dec: 23(8):804-811Lee E, Moon JW, Wang X, Kim C, Li S, Shin BK, Jung W, Kim HK, Kim HK, Lee JY. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer. Hum Pathol. 2015 Aug;46(8):1111-20
4. Pogue-Geile KL, Kim C, Jeong JH, Tanaka N, Bandos H, Gavin PG, Fumagalli D, Goldstein LC, Sneige N, Burandt E, Taniyama Y, Bohn OL, Lee A, Kim SI, Reilly ML, Remillard MY, Blackmon NL, Kim SR, Horne ZD, Rastogi P, Fehrenbacher L, Romond EH, Swain SM, Mamounas EP, Wickerham DL, Geyer CE Jr, Costantino JP, Wolmark N, Paik S. Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. J Natl Cancer Inst. 2013 Dec 4;105(23):1782-8.
5. Kim J, Jeong H, Lee Y, Kim C, Kim H, Kim A HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells. BMC Cancer. 2013 Aug 12;13:383. doi: 10.1186/1471-2407-13-383
6. Perez EA, Press MF, Dueck AC, Jenkins RB, Kim C, Chen B, Villalobos I, Paik S, Buyse M, Wiktor AE, Meyer R, Finnigan M, Zujewski J, Shing M, Stern HM, Lingle WL, Reinholz MM, Slamon DJ. Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Breast Cancer Res Treat. 2013 Feb;138(1):99-108.
7. Gavin PG, Colangelo LH, Fumagalli D, Tanaka N, Remillard MY, Yothers G, Kim C, Taniyama Y, Kim SI, Choi HJ, Blackmon NL, Lipchik C, Petrelli NJ, O'Connell MJ, Wolmark N, Paik S, Pogue-Geile KL. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value. Clin Cancer Res. 2012 Dec 1;18(23):6531-41.
8. Welsh AW, Lannin DR, Young GS, Sherman ME, Figueroa JD, Henry NL, Ryden L, Kim C, Love RR, Schiff R, Rimm DL. Cytoplasmic estrogen receptor in breast cancer. Clin Cancer Res. 2012 Jan 1;18(1):118-26.
9. Kim C, Tang G, Pogue-Geile KL, Costantino JP, Baehner FL, Baker J, Cronin MT, Watson D, Shak S, Bohn OL, Fumagalli D, Taniyama Y, Lee A, Reilly ML, Vogel VG, McCaskill-Stevens W, Ford LG, Geyer CE Jr, Wickerham DL, Wolmark N, Paik S. Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer. J Clin Oncol. 2011 Nov 1;29(31):4160-7.
10. Yang SX, Costantino JP, Kim C, Mamounas EP, Nguyen D, Jeong JH, Wolmark N, Kidwell K, Paik S, Swain SM. Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer. J Clin Oncol. 2010 Jun 20;28(18):2974-81
11. Kim C, Paik S. Gene-expression-based prognostic assays for breast cancer.
Nat Rev Clin Oncol. 2010 Jun;7(6):340-7.
12. Pusztai L, Jeong JH, Gong Y, Ross JS, Kim C, Paik S, Rouzier R, Andre F, Hortobagyi GN, Wolmark N, Symmans WF. Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. J Clin Oncol. 2009 Sep 10;27(26):4287-92
13. Kim C, Taniyama Y, Paik S.: Gene expression-based prognostic and predictive markers for breast cancer: a primer for practicing pathologists. Arch Pathol Lab Med. 2009 Jun;133(6):855-9.
14. Ross DT, Kim CY, Tang G, Bohn OL, Beck RA, Ring BZ, Seitz RS, Paik S, Costantino JP, Wolmark N.: Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials. Clin Cancer Res. 2008 Oct 15;14(20):6602-9.
15. Paik S, Kim C, Wolmark N.:HER2 status and benefit from adjuvant trastuzumab in breast cancer. N Engl J Med. 2008 Mar 27;358(13):1409-11.
16. Kim M Clark-Langone, Jenny Y Wu, Chithra Sangli, Angela Chen, James L Snable, Anhthu Nguyen, James R Hackett, Joffre Baker, Greg Yothers, Chungyeul Kim and Maureen T Cronin: Biomarker discovery for colon cancer using a 761 gene RT-PCR assay. BMC Genomics 2007, Aug 15; 8:279
17. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2006 Aug 10;24(23):3726-34
18. Soonmyung Paik, Chungyeul Kim, Yong-kuk Song and Wan-seop Kim. Technology Insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol 2005 May 2 (5): 246-254
19. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004 Dec 30;351(27):2817-26.

목록